Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Mastocytosis, Systemic × sarilumab × Myeloid × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Mastocytosis, Systemic 1

Interventions

avapritinib 4 midostaurin 3 masitinib 2 Imatinib Mesylate 2 sarilumab 1 ripretinib 1 obatoclax 1 nilotinib 1 ibrutinib 1 denileukin diftitox 1 Thalidomide 1 Phlebotomy 1 Interviews as Topic 1 Everolimus 1 Denosumab 1 Dasatinib 1 Cladribine 1 Brentuximab Vedotin 1 AK002 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT03770273 2024-12-17

Safety and Efficacy of Subcutaneous Sarilumab in Improving the Quality of Life in People With Indolent Systemic Mastocytosis

National Institutes of Health Clinical Center (CC)

Phase 2 Completed

21 enrolled 13 charts

Mastocytosis, Systemic

Data powered by HemOnc (CC BY 4.0) Colophon ⚡